Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Hazard Ratio
Strategies for Assessing and Addressing Confounding
Framing Effects
Models of Health Promotion and Illness Prevention I
Criteria for Causality: Bradford Hill Criteria - II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 16, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
Milo A Puhan1, Sonal Singh, Carlos O Weiss
1Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E6153, Baltimore, MD 21205, USA. mpuhan@jhsph.edu
This study reviews quantitative benefit-harm assessment methods, developing a framework to guide selection based on decision-making context. It highlights the need for clear definitions, outcome identification, and consideration of uncertainty and patient preferences in health care interventions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: